Treatment outcomes of clevudine versus lamivudine at week 48 in na?ve patients with HBeAg positive chronic hepatitis B.
Kim IH, Lee S, Kim SH, Kim SW, Lee SO, Lee ST, Kim DG, Choi CS, Kim HC. Treatment outcomes of clevudine versus lamivudine at week 48 in na?ve patients with HBeAg positive chronic hepatitis B. J Korean Med Sci. 2010 May; 25(5):738-45.